---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-000570"
form_type: "8-K"
ticker: "AMIX"
cik: "0001617867"
company_name: "Autonomix Medical, Inc."
filed_at: "2024-01-31T23:59:59+00:00"
generated_at: "2026-06-06T13:37:15.328644+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Autonomix Medical closes $11.2M IPO, regains cardiology rights via $8M warrant deal

## Summary
- IPO closed Jan 26: 2,234,222 shares at $5.00, gross proceeds $11,171,110 before expenses.
- Regained exclusive worldwide cardiology rights from Impulse Medical in exchange for warrant to buy 1.6M shares at $0.001 per share.
- CEO Lori Bisson cites momentum and on-track first-in-human pancreatic cancer pain study this quarter.
- Warrant shares subject to lockup: 12.5% for 6 months, remainder for 12 months post-IPO.

## SEC filing metadata
- accession: 0001683168-24-000570
- form_type: 8-K
- ticker: AMIX
- cik: 0001617867
- company_name: Autonomix Medical, Inc.
- filed_at: 2024-01-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.02, 8.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1617867/000168316824000570/0001683168-24-000570-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1617867/000168316824000570/autonomix_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-000570
- JSON: https://secwatch.observer/filing/0001683168-24-000570.json
- Plain text: https://secwatch.observer/filing/0001683168-24-000570.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.